Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
Somatuline Depot
lanreotide
- Restricted Restricted to outpatient use.
- Therapeutic Interchange Miscellaneous Program Formulary
Last updated: Mar. 19, 2024
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
lanreotide (Somatuline Depot)
octreotide (SandoSTATIN)
Somatuline Depot is a monthly subcutaneous injection of a somastatin analog for long term treatment of acromegly. It is classified as formulary, restricted to outpatient use.
For Inpatients: See if therapy can be deferred until after hospital discharge. If not, convert to immediate release octreotide injection.
For Updated Formulary Preferred Products (Inpatient and Outpatient): Preferred Products for Select Agents
Reviewed: June 24, 2008